Yonggao K. Mou

Shandong Provincial Key Laboratory Of Neuroimmune Interaction And Regulation, Yantai 264000, Head And Neck Surgery, Yantai Key Laboratory Of Otorhinolaryngologic Diseases
Yantai, 264000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 62 publications

Laryngeal squamous cell carcinoma-derived exosomes promote neuronal axonal growth by remodeling the neural microenvironment

Laryngeal squamous cell carcinoma-derived exosomes promote neuronal axonal growth by remodeling the neural microenvironment

Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery

Published: September 07, 2026

Interaction of head and neck cancer with the nervous system: advances and clinical prospects

Interaction of head and neck cancer with the nervous system: advances and clinical prospects

Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery

Published: April 09, 2026

The dichotomy of central nervous system cancer burden: A global analysis revealing diagnosis-driven epidemics and therapy-resistant mortality.

The dichotomy of central nervous system cancer burden: A global analysis revealing diagnosis-driven epidemics and therapy-resistant mortality.

Journal: Neuro-oncology advances

Published: February 25, 2026

Plasma metabolites link healthy lifestyle to the risk of epilepsy in the UK Biobank.

Plasma metabolites link healthy lifestyle to the risk of epilepsy in the UK Biobank.

Journal: Scientific reports

Published: January 28, 2026

Vebreltinib for Previously Treated Astrocytoma, IDH-Mutant, Grade 4, and Glioblastoma, IDH Wild-Type with PTPRZ1-MET Fusion Gene: A Multicenter, Phase III Randomized, Open-Label Trial.

Vebreltinib for Previously Treated Astrocytoma, IDH-Mutant, Grade 4, and Glioblastoma, IDH Wild-Type with PTPRZ1-MET Fusion Gene: A Multicenter, Phase III Randomized, Open-Label Trial.

Journal: Cancer communications (London, England)

Published: November 22, 2025

An ambispective, observational real-world study of tumor-treating fields for treatment of Chinese patients with newly diagnosed or recurrent/progressive glioblastoma.

An ambispective, observational real-world study of tumor-treating fields for treatment of Chinese patients with newly diagnosed or recurrent/progressive glioblastoma.

Journal: Neuro-oncology advances

Published: October 22, 2025

Development and validation of a nomogram for predicting the prognosis of lung cancer patients with brain metastases harboring EGFR or ALK mutations: a multicenter retrospective study.

Development and validation of a nomogram for predicting the prognosis of lung cancer patients with brain metastases harboring EGFR or ALK mutations: a multicenter retrospective study.

Journal: Scientific reports

Published: October 20, 2025

RGS2 promotes brain metastasis of cisplatin-resistant non-small cell lung cancer through caspase-1/IL-1beta signaling pathway.

RGS2 promotes brain metastasis of cisplatin-resistant non-small cell lung cancer through caspase-1/IL-1beta signaling pathway.

Journal: Neuro-oncology

Published: October 13, 2025

Feasibility and Tumor Dynamics of Daily MRI-Guided Online Adaptive Radiotherapy for Brain Glioma.

Feasibility and Tumor Dynamics of Daily MRI-Guided Online Adaptive Radiotherapy for Brain Glioma.

Journal: CNS neuroscience & therapeutics

Published: September 30, 2025

Development and validation of a customised PRO-CTCAE scale for adult-type diffuse gliomas (VERONICA): a multicentre, prospective, observational cohort study in China.

Development and validation of a customised PRO-CTCAE scale for adult-type diffuse gliomas (VERONICA): a multicentre, prospective, observational cohort study in China.

Journal: EClinicalMedicine

Published: September 26, 2025

Oncolytic virus M1 reinvigorates CD8+ T-cell immunity against glioblastoma through B-cell-dependent antigen cross-presentation in the spleen.

Oncolytic virus M1 reinvigorates CD8+ T-cell immunity against glioblastoma through B-cell-dependent antigen cross-presentation in the spleen.

Journal: Cellular & molecular immunology

Published: September 03, 2025

Updated clinical practice guidelines for the management of adult diffuse gliomas.

Updated clinical practice guidelines for the management of adult diffuse gliomas.

Journal: Cancer letters

Published: September 03, 2025

Showing 1-12 of 62

Last Updated: 09/26/2026